Literature DB >> 22183485

Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?

Jordan A Guenette1, Katherine A Webb, Denis E O'Donnell.   

Abstract

Dynamic hyperinflation (DH) during exercise occurs in most but not all patients with advanced chronic obstructive pulmonary disease (COPD). It is not known whether the presence or absence of DH has implications for dyspnoea and exercise tolerance. Therefore, we compared detailed ventilatory and sensory responses to exercise in hyperinflators and nonhyperinflators with moderate-to-severe COPD. Nonhyperinflators (n=65) were retrospectively identified from a sample of 427 patients and case-matched to a group of hyperinflators (n=65) based on sex, age, body mass index and % predicted forced expiratory volume in 1 s. Resting pulmonary function and constant work rate cycle exercise responses were compared. Hyperinflators decreased inspiratory capacity (IC) from rest to peak exercise by 0.46±0.24 L whereas the nonhyperinflators increased IC by 0.10±0.15 L (p<0.0001). There were no significant group differences in endurance time (9.11±5.98 versus 8.87±5.24 min) or dyspnoea intensity for any given time or ventilation. An inflection in tidal volume versus ventilation occurred in the majority of nonhyperinflators (n=61) and hyperinflators (n=62) at a similar time and ventilation. Mechanical constraints on tidal volume expansion and the attendant rise in dyspnoea intensity were similar in both groups. Dyspnoea intensity during exercise was associated with progressive mechanical constraints on tidal volume expansion regardless of the presence of DH.

Entities:  

Mesh:

Year:  2011        PMID: 22183485     DOI: 10.1183/09031936.00157711

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  36 in total

1.  Effects of transdermal tulobuterol on dyspnea and respiratory function during exercise in patients with chronic obstructive pulmonary disease.

Authors:  Masako Ichikawa; Yuzo Kodama; Kaku Yoshimi; Satomi Shiota; Masaki Kotajima; Mami Nakajyo; Kuniaki Seyama; Yoshinosuke Fukuchi; Kazuhisa Takahashi
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

2.  Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease.

Authors:  Muhammad Ahsan Zafar; Wayne Tsuang; Laura Lach; William Eschenbacher; Ralph J Panos
Journal:  Lung       Date:  2013-01-03       Impact factor: 2.584

3.  Reduced dynamic hyperinflation after LVRS is associated with improved exercise tolerance.

Authors:  Matthew R Lammi; Nathaniel Marchetti; Gerard J Criner
Journal:  Respir Med       Date:  2014-08-06       Impact factor: 3.415

4.  Predictors of dynamic hyperinflation during the 6-minute walk test in stable chronic obstructive pulmonary disease patients.

Authors:  Rui Chen; Lin Lin; Jing-Wei Tian; Bin Zeng; Lei Zhang; Xin Chen; Hai-Yan Yan
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

5.  Endurance exercise performance in acute hypoxia is influenced by expiratory flow limitation.

Authors:  Joshua C Weavil; Joseph W Duke; Jonathon L Stickford; Joel M Stager; Robert F Chapman; Timothy D Mickleborough
Journal:  Eur J Appl Physiol       Date:  2015-03-13       Impact factor: 3.078

Review 6.  A brief review of chronic obstructive pulmonary disease.

Authors:  James C Hogg
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

7.  ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients.

Authors:  Stephen I Rennard; Paul D Scanlon; Gary T Ferguson; Ludmyla Rekeda; Brian T Maurer; Esther Garcia Gil; Cynthia F Caracta
Journal:  Clin Drug Investig       Date:  2013-12       Impact factor: 2.859

8.  Difference Between Slow and Forced Vital Capacity and Its Relationship with Dynamic Hyperinflation in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Larissa Martinez; Diego Rodrigues; Leila Donária; Karina C Furlanetto; Felipe Vilaça Cavallari Machado; Lorena Paltanin Schneider; Marcos Ribeiro; Nidia A Hernandes; Fabio Pitta
Journal:  Lung       Date:  2018-10-29       Impact factor: 2.584

Review 9.  Respiratory and cardiopulmonary limitations to aerobic exercise capacity in adults born preterm.

Authors:  Joseph W Duke; Andrew T Lovering
Journal:  J Appl Physiol (1985)       Date:  2020-08-13

Review 10.  Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD.

Authors:  Roland Buhl; Donald Banerji
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.